Diabetic retinopathy leading to lymphatic neovascularization
- Eye complication in diabetes may contribute to lymphatic neovascularization.
- This eye complication is called proliferative diabetic retinopathy.
- It is a major sight-threatening diabetic complication.
A major sight-threatening diabetic complication called proliferative diabetic retinopathy
is developed by more than 60 percent of diabetes patients 20 years after diagnosis with diabetes despite metabolic control, research at the University Of Helsinki finds.
Proliferative diabetic retinopathy occurs when endothelial cells of the retinal vasculature invade their surroundings and project into the vitreous, the gel substance present inside the eye. Weakness in the new vessels leads to vitreous hemorrhage and a fibrotic response that will eventually pull the retina causing retinal detachment and subsequent vision loss. When these vessels develop, diabetic patients are directed to vitreoretinal surgery
whereby the newly formed pathological fibrovascular tissue is excised.
‘The microenvironment of proliferative diabetic retinopathy may be a supportive environment for the development of pathological neolymphvascularization. This finding may help identify a novel target for diabetic retinopathy therapy.’
As animal models of diabetes do not fully recapitulate this human diabetic eye complication, the research team utilizes these excised neo (fibro) vascular tissues for the in-depth characterization of the disease pathophysiology.
The challenge was to understand the nature of these vessels.
Chronic tissue inflammation is present in proliferative diabetic retinopathy is connected with lymphangiogenesis. Therefore the research team investigated whether proliferative diabetic retinopathy involves the growth or differentiation of new lymphatic vessels.
An expression of lymphatic markers in the proliferative diabetic retinopathy tissues was found.
Knowing the microenvironment is of fundamental importance to understand the mechanisms of a disease. The close collaboration between clinics and research laboratory opened such avenue, says Research Director Kaisa Lehti, Karolinska Institutet and University of Helsinki.
Vitreous samples were collected peri-operatively and used to understand the contribution of the diabetic intraocular microenvironment to the lymphatic endothelial involvement. The researchers found that indeed vitreous samples with increasing concentration of major lymphangiogenic growth factor VEGFC supported the lymphatic endothelial identity and corresponded to fibrovascular tissues with lymphatic marker expression.
Applications of research findings
The functionality of these vessels in PDR pathogenesis remains to be investigated. It is important to know whether these lymphatic vessels develop coincidentally with abnormal blood vessels or only later upon PDR progression and whether they are detrimental or beneficial.
These findings lead to a novel new concept to diabetic microvascular complications and can lead to novel treatment approaches.
Future therapeutic strategies targeting both lymphangiogenesis and angiogenesis may represent promising approaches for treating ischemia and inflammation-associated posterior segment retinal diseases, states ophthalmic surgeon, Dr. Sirpa Loukovaara from Helsinki University Hospital.
- Erika Gucciardo, Sirpa Loukovaara et al. Microenvironment of Proliferative Diabetic Retinopathy Supports Lymphatic Neovascularization, The Journal of Pathology https://doi.org/10.1002/path.5070